RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Updates are delayed or unverified. Check original sources for the latest information.
Your saved research and appointment questionsView recorded trial and retraction changes
Wilson Disease: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Improving access to rare-disease knowledge: A retrieval-augmented question answering framework for Wilson's disease.
Chandra Tushar et al., Computers in biology and medicine (15 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42790229/
- 2.
Copper sensing by urease in synthetic urine: application for Wilson's disease monitoring.
Checcozzo Agata et al., Talanta (15 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42880031/
- 3.
Is there any research on ongoing symptoms in paediatric patients in remission from Wilson's disease?
Tripdatabase, Zenodo (CERN European Organization for Nuclear Research) (14 October 2026)
https://doi.org/10.5281/zenodo.23363041
- 4.
Temporal interference stimulation for treating Wilson disease: A prospective clinical and functional MRI study.
Cheng Nan et al., Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics (12 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42863346/
- 5.
Cornea And Anterior Chamber Angle Evaluation Using Anterior Segment Optical Coherence Tomography In Pediatric Patients With Wilson Disease
Dr Ahmed Refaat et al., ESCRS Abstracts (9 October 2026)
https://doi.org/10.82333/3461-2g63
Clinical Trials : Australian Sites
Ask your doctor whether you or your child may be eligible for any of these trials. Each has its ID and full eligibility criteria at the link shown.
- 1.
Study of ALXN1840 Versus Standard of Care in Pediatric Participants With Wilson Disease
NCT05047523 · TERMINATED · Phase 3 · Alexion Pharmaceuticals, Inc.
Ages 3 to 17
https://clinicaltrials.gov/study/NCT05047523
- 2.
Efficacy and Safety of ALXN1840 Administered for 48 Weeks Versus Standard of Care in Participants With Wilson Disease
NCT03403205 · TERMINATED · Phase 3 · Alexion Pharmaceuticals, Inc.
Ages 12 and over
https://clinicaltrials.gov/study/NCT03403205
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Wilson Disease
Wilson disease is a genetic condition where copper accumulates in the liver, brain, and other organs due to a faulty ATP7B gene. If untreated it causes liver failure and neurological problems. Early detection and lifelong copper-chelation therapy can prevent serious complications and allow a near-normal life.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
OBJECTIVE: Wilson's disease is a rare genetic disorder with a large but highly fragmented body of biomedical literature spanning more than a century of research. Although thousands of articles are available through PubMed, this knowledge remains difficult to access in a consolidated, query-driven manner for researchers, clinicians, and students. Existing large language models (LLMs) offer conversational access to information but often lack domain grounding, leading to hallucinations and unreliable responses in biomedical settings. In this work, we introduce WilsonLitQA, a literature-grounded retrieval-augmented question answering resource that enables the scientific community to query the complete PubMed literature on Wilson's disease, capturing canonical biological, clinical, and pathophysiological knowledge related to the disease. METHODS: Our framework integrates hybrid information retrieval with generative language models, enabling users to query the Wilson's disease literature as a unified knowledge resource rather than as isolated papers. We have systematically evaluated multiple open-source and proprietary LLMs under zero-shot and few-shot in-context learning settings, assessing their ability to deliver accurate, complete, and non-hallucinated responses when supported by retrieval. RESULTS: Our results demonstrate that retrieval grounding substantially improves biological accuracy and clinical relevance, and that smaller, deployable language models (on the order of 7B parameters) can perform competitively when paired with a well-designed retrieval pipeline. CONCLUSION: To support transparency, reproducibility, and community-driven development, the complete WilsonLitQA implementation is publicly available (https://dhanjal-lab.iiitd.edu.in/wilsonlitqa.html). Together, this work positions retrieval-augmented question answering as a consolidated, continuously extensible knowledge interface for rare diseases, offering the scientific community a practical tool to navigate, interpret, and query the growing biomedical literature on Wilson's disease.
Common Questions
What is Wilson Disease?
Wilson disease is a genetic condition where copper accumulates in the liver, brain, and other organs due to a faulty ATP7B gene. If untreated it causes liver failure and neurological problems. Early detection and lifelong copper-chelation therapy can prevent serious complications and allow a near-normal life.
How many clinical trials are available for Wilson Disease?
RareWays currently indexes 40 clinical trials for Wilson Disease, of which 7 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for Wilson Disease come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Wilson Disease.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.